跳至主要内容
临床试验/JPRN-UMIN000004495
JPRN-UMIN000004495已完成4 期

Investigation of the efficacy of an antiemetic, aprepitant and its drug interaction with prednisolone in CHOP or R-CHOP therapy - Investigation of the efficacy of aprepitant and its drug interaction with prednisolone in (R-)CHOP therapy

Division of Hematology, University of Tsukuba0 个研究点目标入组 12 人开始时间: 2010年11月3日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The use of drugs which affect metabolism of aprepitant and prednisolone, the use of antiemetics or drugs with antiemetic effect which is not prescribed within 48 hours before (R-)CHOP initiation, irradiation to the abdomen or pelvis within 6 days before (R-)CHOP initiation, the onset of vomitting or dry vomiting within 24 hours before (R-)CHOP initiation, symptomatic brain metastasis, beeing pregnant or lactating, the possibility of pregnancy, using oral contraceptive, previous use of aprepitant, diabetes mellitus with drug treatment, HbA1c >= 6.5 %, fasting blood glucose >= 126 mg/dl, psychiatric disorder, a patients who is considered as ineligible by the attending doctor.

研究者

发起方
Division of Hematology, University of Tsukuba

相似试验

Investigation of the efficacy of an antiemetic,... | 临床试验